Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer

Oncology Reports

Volumn 18, Issue 2, 2007, Pages 329-336

  Suzuki, Takahisa ^a   Yoshida, Kazuhiro ^a   Wada, Yoshiyuki ^a   Hamai, Yoichi ^a   Sentani, Kazuhiro ^b   Oue, Naohide ^b   Yasui, Wataru ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

DNA demethylation; DNA methylation; Gastric cancer; Melanoma associated antigen A1; Serial analysis of gene expression

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; PACLITAXEL; TAXOID; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; DNA METHYLATION; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; PROGNOSIS; STOMACH TUMOR; TUMOR CELL LINE; TUMOR RECURRENCE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; TAXOIDS; TRANSFECTION;

EID: 34548536448     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.2.329     Document Type: Article

References (37)

1. Yoshida K, Hirabayashi N, Takiyama W, et al: Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer. Anticancer Res 24: 1843-1851, 2004. (Pubitemid 38954598)
2. Yoshida K, Ninomiya M, Takakura N, et al: Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clin Cancer Res 12: 3402-3407, 2006.
3. Ringel I and Horwitz SB: Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83: 288-291, 1991.
4. Wada Y, Yoshida K, Suzuki T, et al: Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines. Int J Cancer 119: 783-791, 2006. (Pubitemid 44055889)
5. Yasui W, Sentani K, Motoshita J and Nakayama H: Molecular pathobiology of gastric cancer. Scand J Surg 95: 225-231, 2006. (Pubitemid 46089255)
6. Ushijima T and Sasako M: Focus on gastric cancer. Cancer Cell 5: 121-125, 2004. (Pubitemid 38283798)
7. Yasui W, Oue N, Ito R, Kuraoka K and Nakayama H: Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 95: 385-392, 2004. (Pubitemid 38832680)
8. Oue N, Hamai Y, Mitani Y, et al: Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405, 2004. (Pubitemid 38523892)
9. Aung PP, Oue N, Mitani Y, et al: Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25: 2546-2557, 2006.
10. Duan Z, Feller AJ, Toh HC, Makastorsis T and Seiden MV: TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line. Gene 229: 75-81, 1999. (Pubitemid 29148309)
11. Feller AJ, Duan Z, Penson R, Toh HC and Seiden MV: TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma. Anticancer Res 20: 4147-4151, 2000. (Pubitemid 32141756)
12. Nimmrich I, Erdmann S, Melchers U, et al: Seven genes that are differentially transcribed in colorectal tumor cell lines. Cancer Lett 160: 37-43, 2000.
13. Chen Z, Zhu B and Wu Y: Expression of TRAG-3 antigen in non-small-cell lung carcinomas. Lung Cancer 38: 101-102, 2002. (Pubitemid 35303357)
14. Wu YZ, Zhao TT, Ni B, Zou LY, Liu HL and Zhu B: Expression of TRAG-3 in breast cancer. Int J Cancer 107: 167-168, 2003.
15. Zhu B, Chen Z, Cheng X, et al: Identification of HLA-A*0201- restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen. Clin Cancer Res 9: 1850-1857, 2003. (Pubitemid 36554613)
16. Duan Z, Duan Y, Lamendola DE, et al: Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 9: 2778-2785, 2003. (Pubitemid 36842124)
17. Miyagawa N, Kono K, Mimura K, Omata H, Sugai H and Fujii H: A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells. Oncology 70: 54-62, 2006.
18. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ and Chen YT: Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188: 22-32, 2002. (Pubitemid 35398862)
19. Honda T, Tamura G, Waki T, et al: Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer 90: 838-843, 2004. (Pubitemid 38406595)
20. Lauren P: The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma: an attempt at histological classification. APMIS 64: 31-49, 1965.
21. TNM classification of malignant tumors. Sobin LH and Wittekind CH (eds). 6th edition. John Wiley & Sons, New York, pp65-68, 2002.
22. Rimoldi D, Salvi S, Reed D, et al: cDNA and protein characterization of human MAGE-10. Int J Cancer 82: 901-907, 1999. (Pubitemid 29384344)
23. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
24. Ochiai A, Yasui W and Tahara E: Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 76: 1064-1071, 1985. (Pubitemid 16175800)
25. Yasui W, Ayhan A, Kitadai Y, et al: Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 53: 36-41, 1993. (Pubitemid 23018419)
26. Inoue H, Li J, Honda M, et al: MAGE-1 mRNA expression in gastric carcinoma. Int J Cancer 64: 76-77, 1995.
27. Mori M, Inoue H, Mimori K, et al: Expression of MAGE genes in human colorectal carcinoma. Ann Surg 224: 183-188, 1996. (Pubitemid 26272065)
28. Utsunomiya T, Inoue H, Tanaka F, et al: Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma. Ann Surg Oncol 11: 934-940, 2004. (Pubitemid 40486680)
29. Jung EJ, Kim MA, Lee HS, et al: Expression of family A melanoma antigen in human gastric carcinoma. Anticancer Res 25: 2105-2111, 2005. (Pubitemid 40904611)
30. Fujie T, Tahara K, Tanaka F, Mori M, Takesako K and Akiyoshi T: A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes. Int J Cancer 80: 169-172, 1999. (Pubitemid 29001716)
31. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428, 2002. (Pubitemid 34587077)
32. Oue N, Motoshita J, Yokozaki H, et al: Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 198: 55-59, 2002. (Pubitemid 34966207)
33. Shutoh M, Oue N, Aung PP, et al: DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer 104: 1609-1619, 2005. (Pubitemid 41437423)
34. Oue N, Mitani Y, Motoshita J, et al: Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 106: 1250-1259, 2006. (Pubitemid 43363901)
35. Morishima N, Nakanishi K, Takenouchi H, Shibata T and Yasuhiko Y: An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 277: 34287-34294, 2002.
36. Peikert T, Specks U, Farver C, Erzurum SC and Comhair SA: Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Cancer Res 66: 4693-4700, 2006.
37. Ehrlich M: DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413, 2002.